BDBM50116764 3-[1-Pyridin-2-yl-meth-(Z)-ylidene]-6-[1-[4-(3-pyridin-3-yl-propoxy)-phenyl]-meth-(Z)-ylidene]-piperazine-2,5-dione::CHEMBL77246
SMILES: O=c1[nH]\c(=C/c2ccccn2)c(=O)[nH]\c1=C/c1ccc(OCCCc2cccnc2)cc1
InChI Key: InChIKey=BJERXUSOIKLRIV-OZKZUFLSSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Plasminogen activator inhibitor-1 (Homo sapiens (Human)) | BDBM50116764 (3-[1-Pyridin-2-yl-meth-(Z)-ylidene]-6-[1-[4-(3-pyr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenova Ltd. Curated by ChEMBL | Assay Description Inhibitory concentration required against Plasminogen activator inhibitor 1. | Bioorg Med Chem Lett 12: 2367-70 (2002) BindingDB Entry DOI: 10.7270/Q2319V6B | |||||||||||
More data for this Ligand-Target Pair |